David Horsley

This inventor holds 23 USPTO granted patents and 2 published patent applications, plus 11 CIPO patents and 9 EPO patents, primarily in Neurodegenerative Disease. Top assignee: Wista Laboratories Ltd.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Horsley. Retrieved from https://idiyas.com/inventor/david-horsley-axipg12g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 2)

% Patents Active = 91.3

CIPO Patents = 11

EPO Patents = 9 (Patent Applications = 6)

Average Co-Inventor Count = 6.4

ph-index = 7

Forward Citations = 123(Granted Patents)

Location History:

South Aberdeenshire, GB (2010)
Ellon, GB (2012)
Old Aberdeen, GB (2016)
Aberdeen, GB (2008 - 2024)
Aberdeenshire, GB (2020 - 2024)

Company Filing History:

23 out of 59

Wista Laboratories Ltd.

patents

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Phenothiazine Salts

Tau Aggregation

Neurofibrillary Labels

Protein Aggregation

Xanthylium Salts

Thioninium Compounds

Neurodegenerative Disorders

Inhibitors

Alzheimer's Treatment

Materials

Methods

Conditions

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12324810 - 3, 7-diamino-10H-phenothiazine salts and their use (2025-06-10),

2. 12064439 - Phenothiazine diaminium salts and their use (2024-08-20),

3. 11951110 - 3, 7-diamino-10H-phenothiazine salts and their use (2024-04-09),

4. 11344558 - 3, 7-diamino-10H-phenothiazine salts and their use (2022-05-31),

5. 11180464 - Phenothiazine diaminium salts and their use (2021-11-23),

6. 10864216 - Phenothiazine diaminium salts and their use (2020-12-15),

7. 10399955 - 3,6-disubstituted xanthylium salts (2019-09-03),

8. 9907804 - Phenothiazine diaminium salts and their use (2018-03-06),

9. 9549933 - 3,6-disubstituted xanthylium salts (2017-01-24),

10. 9283230 - Phenothiazine diaminium salts and their use (2016-03-15),

11. 9174954 - 3,7-diamino-10H-phenothiazine salts and their use (2015-11-03),

12. 8710051 - 3,7-diamino-10H-phenothiazine salts and their use (2014-04-29),

13. 8658665 - 3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies (2014-02-25),

14. 8263589 - Inhibitors of protein aggregation (2012-09-11),

15. 8097615 - Neurofibrillary labels (2012-01-17),

Title: David Horsley: Innovator in Pharmaceutical Chemistry

Introduction

David Horsley, based in Aberdeen, GB, is a prominent inventor with a remarkable portfolio of 22 patents in the field of pharmaceutical chemistry. His innovative contributions have significantly advanced the understanding and treatment of various diseases, particularly in the realm of neurodegenerative disorders.

Latest Patents

Horsley's latest patents include groundbreaking compounds and compositions targeting critical health issues. One of his notable patents, titled "Phenothiazine diaminium salts and their use," discloses compounds that have potential applications in treating diseases. Another significant patent, "3, 7-diamino-10H-phenothiazine salts and their use," describes methods for preparing reduced forms of 3,7-diamino-10H-phenothiazine (DAPTZ) compounds. These patents are focused on developing stable, high-purity pharmaceutical compositions essential for treating tauopathies, such as Alzheimer's disease.

Career Highlights

David Horsley has built a robust career at Wista Laboratories Ltd., where he continues to push the boundaries of pharmaceutical research and innovation. His dedication to enhancing drug formulations has led to the creation of several impactful patents that provide new therapeutic avenues for various diseases.

Collaborations

Throughout his career, Horsley has worked alongside esteemed colleagues, including Claude Michel Wischik and Charles Robert Harrington. Their collective expertise has fostered a collaborative environment conducive to groundbreaking research and development in the pharmaceutical sector.

Conclusion

David Horsley's contributions to the pharmaceutical industry are invaluable. With 22 patents to his name, he remains a driving force in innovation, particularly in the development of treatments for debilitating diseases. His work not only enhances scientific understanding but also brings hope to countless individuals affected by neurodegenerative conditions.

Profile summary based on public USPTO records.